Skip to main content
Top
Published in: Journal of Translational Medicine 1/2004

Open Access 01-12-2004 | Research

Ambiguous allele combinations in HLA Class I and Class II sequence-based typing: when precise nucleotide sequencing leads to imprecise allele identification

Authors: Sharon D Adams, Kathleen C Barracchini, Deborah Chen, FuMeei Robbins, Lu Wang, Paula Larsen, Robert Luhm, David F Stroncek

Published in: Journal of Translational Medicine | Issue 1/2004

Login to get access

Abstract

Sequence-based typing (SBT) is one of the most comprehensive methods utilized for HLA typing. However, one of the inherent problems with this typing method is the interpretation of ambiguous allele combinations which occur when two or more different allele combinations produce identical sequences. The purpose of this study is to investigate the probability of this occurrence. We performed HLA-A,-B SBT for Exons 2 and 3 on 676 donors. Samples were analyzed with a capillary sequencer. The racial distribution of the donors was as follows: 615-Caucasian, 13-Asian, 23-African American, 17-Hispanic and 8-Unknown. 672 donors were analyzed for HLA-A locus ambiguities and 666 donors were analyzed for HLA-B locus ambiguities. At the HLA-A locus a total of 548 total ambiguous allele combinations were identified (548/1344 = 41%). Most (278/548 = 51%) of these ambiguities were due to the fact that Exon 4 analysis was not performed. At the HLA-B locus 322 total ambiguous allele combinations were found (322/1332 = 24%). The HLA-B*07/08/15/27/35/44 antigens, common in Caucasians, produced a large portion of the ambiguities (279/322 = 87%). A large portion of HLA-A and B ambiguous allele combinations can be addressed by utilizing a group-specific primary amplification approach to produce an unambiguous homozygous sequence. Therefore, although the prevalence of ambiguous allele combinations is high, if the resolution of these ambiguities is clinically warranted, methods exist to compensate for this problem.
Appendix
Available only for authorised users
Literature
1.
go back to reference Provenzano M, Mocellin S, Bettinotti M, Preuss J, Monsurro V, Marincola FM, Stroncek D: Identification of immune dominant cytomegalovirus epitopes using quantitative real-time polymerase chain reactions to measure interferon-gamma production by peptide-stimulated peripheral blood mononuclear cells. J Immunother. 2002, 25: 342-351. 10.1097/00002371-200207000-00006.CrossRefPubMed Provenzano M, Mocellin S, Bettinotti M, Preuss J, Monsurro V, Marincola FM, Stroncek D: Identification of immune dominant cytomegalovirus epitopes using quantitative real-time polymerase chain reactions to measure interferon-gamma production by peptide-stimulated peripheral blood mononuclear cells. J Immunother. 2002, 25: 342-351. 10.1097/00002371-200207000-00006.CrossRefPubMed
2.
go back to reference Provenzano M, Mocellin S, Bonginelli P, Nagorsen D, Kwon SW, Stroncek D: Ex vivo screening for immunodominant viral epitopes by quantitative real time polymerase chain reaction (qRT-PCR). J Transl Med. 2003, 1: 12-10.1186/1479-5876-1-12.PubMedCentralCrossRefPubMed Provenzano M, Mocellin S, Bonginelli P, Nagorsen D, Kwon SW, Stroncek D: Ex vivo screening for immunodominant viral epitopes by quantitative real time polymerase chain reaction (qRT-PCR). J Transl Med. 2003, 1: 12-10.1186/1479-5876-1-12.PubMedCentralCrossRefPubMed
3.
go back to reference Adams SD, Krausa P, McGinnis M, Simonis T, Stein J, Marincola F: Practicality of High Throughput HLA Sequence-Based Typing. ASHI Quarterly. 2001, 25: 54-57. Adams SD, Krausa P, McGinnis M, Simonis T, Stein J, Marincola F: Practicality of High Throughput HLA Sequence-Based Typing. ASHI Quarterly. 2001, 25: 54-57.
4.
go back to reference Cox ST, McWhinnie AJ, Robinson J, Marsh SG, Parham P, Madrigal JA, Little AM: Cloning and sequencing full-length HLA-B and -C genes. Tissue Antigens. 2003, 61: 20-48. 10.1034/j.1399-0039.2003.610103.x.CrossRefPubMed Cox ST, McWhinnie AJ, Robinson J, Marsh SG, Parham P, Madrigal JA, Little AM: Cloning and sequencing full-length HLA-B and -C genes. Tissue Antigens. 2003, 61: 20-48. 10.1034/j.1399-0039.2003.610103.x.CrossRefPubMed
5.
go back to reference Robinson J, Malik A, Parham P, Bodmer JG, Marsh SGE: IMGT/HLA database – a sequence database for the human major histocompatibility complex. Tissue Antigens. 2000, 55: 28-27. 10.1034/j.1399-0039.2000.550314.x.CrossRef Robinson J, Malik A, Parham P, Bodmer JG, Marsh SGE: IMGT/HLA database – a sequence database for the human major histocompatibility complex. Tissue Antigens. 2000, 55: 28-27. 10.1034/j.1399-0039.2000.550314.x.CrossRef
6.
go back to reference Tilanus M: 13th IWHG Technical Manual. Genomic Analysis of the Human MHC, Chapter 6, SBT Resolution and Ambiguities. Tilanus M: 13th IWHG Technical Manual. Genomic Analysis of the Human MHC, Chapter 6, SBT Resolution and Ambiguities.
7.
go back to reference Lobashevsky AL, Senkbeil RW, Townsend JE, Thomas JM: Does Sequence Based Typing Always Provide the High Level of Resolution?. Human Immunology. 2000, 61 (Supplement 2): S117- Lobashevsky AL, Senkbeil RW, Townsend JE, Thomas JM: Does Sequence Based Typing Always Provide the High Level of Resolution?. Human Immunology. 2000, 61 (Supplement 2): S117-
8.
go back to reference Tiercy JM, Marsh SG, Schreuder GM, Albert E, Fischer G, Wassmuth R: Guidelines for nomenclature usage in HLA reports: ambiguities and conversion to serotypes. Eur J Immunogenet. 2002, 29: 273-274. 10.1046/j.1365-2370.2002.00336.x.CrossRefPubMed Tiercy JM, Marsh SG, Schreuder GM, Albert E, Fischer G, Wassmuth R: Guidelines for nomenclature usage in HLA reports: ambiguities and conversion to serotypes. Eur J Immunogenet. 2002, 29: 273-274. 10.1046/j.1365-2370.2002.00336.x.CrossRefPubMed
9.
go back to reference Xiangjun L, Kalve I, Larsen P, Parlow M, Ramon D, Vornsand J, Walsh B, Warden M: Evaluation of the Capability of RSCA to Separate HLA-A Alleles, which have only a single base Difference. Human Immunology. 2001, 62 (Supplement 1): S151- Xiangjun L, Kalve I, Larsen P, Parlow M, Ramon D, Vornsand J, Walsh B, Warden M: Evaluation of the Capability of RSCA to Separate HLA-A Alleles, which have only a single base Difference. Human Immunology. 2001, 62 (Supplement 1): S151-
10.
go back to reference Wang Y, Ramon D, Branden M, Kalve I, Liu X, Wang L: Pyrosequencing Based Genotyping of the HLA DRB1 Locus. Human Immunology. 2002, 63 (Supplement 1): S98-10.1016/S0198-8859(02)00662-6.CrossRef Wang Y, Ramon D, Branden M, Kalve I, Liu X, Wang L: Pyrosequencing Based Genotyping of the HLA DRB1 Locus. Human Immunology. 2002, 63 (Supplement 1): S98-10.1016/S0198-8859(02)00662-6.CrossRef
11.
go back to reference Etokebe GE, Opsahl M, Tveter AK, Lie BA, Thorsby E, Vartdal F, Spurkland A: Physical separation of HLA-A alleles by denaturing high-performance liquid chromatography. Tissue Antigens. 2003, 61: 443-450.CrossRefPubMed Etokebe GE, Opsahl M, Tveter AK, Lie BA, Thorsby E, Vartdal F, Spurkland A: Physical separation of HLA-A alleles by denaturing high-performance liquid chromatography. Tissue Antigens. 2003, 61: 443-450.CrossRefPubMed
Metadata
Title
Ambiguous allele combinations in HLA Class I and Class II sequence-based typing: when precise nucleotide sequencing leads to imprecise allele identification
Authors
Sharon D Adams
Kathleen C Barracchini
Deborah Chen
FuMeei Robbins
Lu Wang
Paula Larsen
Robert Luhm
David F Stroncek
Publication date
01-12-2004
Publisher
BioMed Central
Published in
Journal of Translational Medicine / Issue 1/2004
Electronic ISSN: 1479-5876
DOI
https://doi.org/10.1186/1479-5876-2-30

Other articles of this Issue 1/2004

Journal of Translational Medicine 1/2004 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.